However, haloperidol, a D2R antagonist, has limited efficacy in the treatment of TS with severe extrapyramidal side effects (Silva et al., 1996; Mogwitz et al., 2013; Egolf and Coffey, 2014). The gene discussed is DRD2; the disease is Timothy syndrome.